What happened with AIRS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
AirSculpt Technologies serves people seeking to remove unwanted fat or reshape their bodies through AirSculpt centers in the United States and Canada. Its core AirSculpt procedure removes fat while patients remain awake, without general anesthesia. Patients can also have their own fat transferred to other body areas or receive skin-tightening treatments. These are elective procedures that patients pay for themselves; government and private health insurance do not cover them.
Affiliated medical practices provide the clinical care and contract with surgeons, while AirSculpt’s subsidiaries handle management and administration. Patients pay upfront, and the medical practices generally bill for surgeons’ services. The subsidiaries collect management fees, either fixed monthly amounts or, where permitted, fees partly tied to the practices’ revenue. State laws restrict corporate control of medical practice and the sharing of medical fees, shaping these arrangements. Local rules also limit how much fat surgeons may remove.
The business depends on attracting patients willing and able to pay, access to third-party patient financing, and recruiting surgeons. It also relies on Euromi as the sole manufacturer of the handpieces used in AirSculpt procedures, with no qualified alternative supplier.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
AirSculpt’s results hinge on demand for privately paid cosmetic procedures and how fully its centers are used, while its procedures also depend on a specialized handpiece supplied by Euromi S.A.
SBC Medical Group Holdings Incorporated shares AirSculpt’s exposure to consumers’ willingness to pay for elective cosmetic treatments: AirSculpt runs body-contouring centers, while SBC earns fees supporting branded aesthetic clinics in Japan. SBC’s clinic-management revenue offers a read on that demand in Japan, rather than on AirSculpt’s own procedure volumes.
LifeMD, Inc. gives consumers an alternative to AirSculpt’s paid body-contouring and fat-removal procedures through its virtual weight-management program. Watch the program’s patient subscriptions—approximately 81,000 at December 31, 2025—to gauge uptake of that alternative, rather than LifeMD’s broader healthcare revenue.
Hims & Hers Health indirectly competes with AirSculpt for consumers seeking changes in body size and appearance, offering medication-based weight loss through online consultations rather than fat-removal procedures. Its weight-loss treatments and prescription offerings are the relevant news to watch for AirSculpt, not its other consumer-health products.
Fed Interest Rate Decision
The Fed’s rate decision signals whether borrowing costs are rising or falling, which can change patients’ monthly payments for financed AirSculpt procedures and AirSculpt’s interest expense on variable-rate debt.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher rates can raise monthly payments for patients using third-party financing, potentially making elective procedures less accessible and reducing case volume and revenue; they can also increase AirSculpt’s interest expense and refinancing costs on variable-rate debt.
If it comes in below expectations
Lower rates can ease monthly payments for patients using third-party financing, potentially making elective procedures more accessible and supporting case volume and revenue; they can also reduce AirSculpt’s interest expense and refinancing costs on variable-rate debt.
AirSculpt Technologies, Inc. earningsThis company
AirSculpt earns from patients paying out of pocket for body-contouring procedures, and this report will show whether case volume and revenue per case can steady revenue and better absorb center costs.
Read procedure volume alongside average revenue per case. More cases with average revenue holding would show that more patients are paying and the revenue base is improving. If cases keep falling, or revenue holds up only because each case brings in more, demand remains weak and fixed center costs such as rent and nursing are harder to absorb, keeping pressure on profit.
Hims & Hers Health, Inc. earningsHIMS
Hims & Hers Health's report will show demand for medication-based weight loss online, giving AirSculpt a read on whether consumers are choosing a non-surgical alternative to its procedures.
Focus on Hims & Hers' weight-loss treatments and prescriptions, not its other health products. Rising uptake would mean more consumers are choosing medication rather than procedures to change body size, putting greater substitution pressure on AirSculpt's self-paid services; weak uptake would offer less evidence that this alternative is drawing customers away.
